DNTH · Company research
Dianthus Therapeutics, Inc. Common Stock (DNTH): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 84.88 | $5,082,401,838.04 | 4971852838.04 | — | — | — | 6678.5832300131406045 | 4.3364278390307374 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.